Ireland
--:--IST
Enrolling by invitation Not applicable

Tune Up Your Back: Soundwave Wellness Study

NCT07256626 · tracked via the Priya Life Science USA tracker
Phase
Not applicable
Started
2025-08-25
Last updated
2025-12-26

Condition(s) studied

Pain, Back

Investigational drug(s) / intervention(s)

WAVWatch 2.0

WAVWatch 2.0: The WAVwatch sound frequency therapy device employs acoustic waves absorbed through the skin to promote wellness, with manufacturers and users reporting minimal safety risks

Study summary

Looking to support your back mobility and overall comfort? Join our study exploring WAVwatch 2.0, an innovative soundwave therapy device. This non-invasive technology is designed for individuals who want to maintain easy movement and flexibility without constantly reaching for over-the-counter options. By joining, you'll discover how this gentle approach may help support everyday back comfort, mobility, and flexibility.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol.

Primary outcome measure(s)

  • PROMIS® Item Bank/Scale v.2.0 - Pain Behavior Survey — Change from baseline (Day 1-3) in pain behavior at 4 weeks after the start of the intervention (Day 27-33)
    This survey aims to understand individual behaviors and reactions when experiencing pain within the past 7 days.
  • Quality of Life and Health Survey — Change from baseline (Day 1-3) in quality of life at 4 weeks after the start of the intervention (Day 27-33)
    This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
  • ROMIS® Numeric Rating Scale v.1.0 - Pain Intensity 1a — Change from baseline (Day 1-3) in pain intensity at 1 week after the start of the intervention (Day 4-10)
    This survey is designed to understand the level of pain experienced by the participant in the past 7 days. The responses will help in assessing the pain intensity from no pain to worst imaginable pain.

Trial sites (1)

FacilityCityRegionStatus
Efforia New York New York
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07256626 on ClinicalTrials.gov ↗ ← All trials in the USA